Gallant Raises $15M for Pet Stem Cell Therapies

Jan 30, 2024•almost 2 years ago

Amount Raised

$15 Million

San DiegoTherapeuticsBiotechnologyHealth Care

Investors

Digitalis Ventures

Description

Gallant Therapeutics announced it had raised more than $15 million in Series A funding from a leading investor syndicate, enabling the company to further its mission to make U.S. Food and Drug Administration-approved, stem cell therapies a reality for pets.

Company Information

Company

Gallant Therapeutics

Location

12130 MILLENNIUM DRIVE

San Diego, California, United States

About

Gallant Therapeutics is a San Diego-based full-development clinical stage animal health biotechnology company that is pioneering ready-to-use stem cell therapies for pets, with the potential to transform pet diseases by re-establishing the normal biological function of tissues and organs.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends